Breaking News Instant updates and real-time market news.

ARNA

Arena Pharmaceuticals

$45.15

-0.45 (-0.99%)

09:01
01/16/20
01/16
09:01
01/16/20
09:01

Arena Pharmaceuticals' APD418 granted FDA Fast Track designation

Arena Pharmaceuticals announced that the U.S. FDA granted Fast Track designation for APD418, a beta3-adrenergic receptor antagonist and cardiac myotrope, in development for the treatment of decompensated heart failure.

  • 16

    Jan

ARNA Arena Pharmaceuticals
$45.15

-0.45 (-0.99%)

01/29/19
01/29/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Dell Technologies (DELL) initiated with an Outperform at Raymond James. 2. MasterCard (MA) and Visa (V) were initiated with a Buy at Jefferies. 3. Eiger BioPharmaceuticals (EIGR) initiated with an Outperform at Baird. 4. Arena Pharmaceuticals (ARNA) assumed with an Overweight at Cantor Fitzgerald. 5. Southern Copper (SCCO) reinstated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/03/19
FBCO
04/03/19
NO CHANGE
Target $77
FBCO
Outperform
Arena Pharmaceuticals price target raised to $77 from $63 at Credit Suisse
Credit Suisse analyst Martin Auster raised his price target for Arena Pharmaceuticals to $77 from $63 as he believes etrasimod has an opportunity to emerge as the oral agent of choice in the treatment of moderate-to-severe IBD. While several effective biologic approaches exist to manage IBD, the analyst received feedback that a safe and effective oral agent will likely play a major long-term role in managing patients' refractory to SoC, TNF-alpha antagonists. Etrasimod may be the 3rd or 4th oral agent to the market, but Auster sees its clinical profile supporting it as the best agent. The analyst reiterates an Outperform rating on the shares.
11/13/19
BOFA
11/13/19
INITIATION
Target $51
BOFA
Neutral
Arena Pharmaceuticals initiated with a Neutral at BofA/Merrill
BofA/Merrill analyst Jason Gerberry initiated coverage of Arena Pharmaceuticals with a Neutral rating and $51 price target. The analyst believes the company has a potentially best-in-class oral immune-modulator, but he sees a lack of catalysts for its key irritable bowel disease program.
01/08/20
JMPS
01/08/20
NO CHANGE
Target $79
JMPS
Outperform
Arena Pharmaceuticals has right management team in place, says JMP Securities
JMP Securities analyst Jason Butler reiterated an Outperform rating and $79 price target on Arena Pharmaceuticals after the company provided an update on its corporate outlook for 2020 and beyond, with the highlights being plans for eight Phase 2 and 3 readouts by year-end 2021 and at least one new IND each year through 2024. In a research note to investors, Butler says he believes the company remains well funded and has the right management team in place to execute on the expanding opportunity set.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
01/21/20
01/21
12:17
01/21/20
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
01/21/20
01/21
12:16
01/21/20
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$88.47

-0.21 (-0.24%)

12:13
01/21/20
01/21
12:13
01/21/20
12:13
Periodicals
Philip Morris CEO wants tobacco advertising rules relaxed, Telegraph says »

Philip Morris…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$24.37

0.41 (1.71%)

, VFC

VF Corp.

$94.68

0.43 (0.46%)

12:10
01/21/20
01/21
12:10
01/21/20
12:10
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks in the U.S. opened…

HAL

Halliburton

$24.37

0.41 (1.71%)

VFC

VF Corp.

$94.68

0.43 (0.46%)

COLM

Columbia Sportswear

$98.09

2.5 (2.62%)

YETI

Yeti

$35.95

1.72 (5.02%)

AAL

American Airlines

$27.85

-0.54 (-1.90%)

DAL

Delta Air Lines

$59.78

-2.23 (-3.60%)

UAL

United Airlines

$86.72

-2.96 (-3.30%)

LVS

Las Vegas Sands

$71.07

-3 (-4.05%)

WYNN

Wynn Resorts

$144.98

-6.53 (-4.31%)

MLCO

Melco Resorts & Entertainment

$23.31

-1.7 (-6.80%)

OMI

Owens & Minor

$6.49

0.97 (17.57%)

BYND

Beyond Meat

$123.42

14.22 (13.02%)

SBUX

Starbucks

$93.09

-0.53 (-0.57%)

ARWR

Arrowhead

$49.05

-7.37 (-13.06%)

WW

WW

$38.50

-3.43 (-8.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

  • 28

    Jan

  • 06

    Feb

  • 04

    Mar

  • 23

    Mar

SCWX

Secureworks

$16.55

0.19 (1.16%)

12:07
01/21/20
01/21
12:07
01/21/20
12:07
Hot Stocks
Secureworks, Carahsoft expand partnership »

Carahsoft Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$11.15

1.18 (11.84%)

12:05
01/21/20
01/21
12:05
01/21/20
12:05
Options
Cel Sci call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

MDT

Medtronic

$120.36

1.38 (1.16%)

12:03
01/21/20
01/21
12:03
01/21/20
12:03
Hot Stocks
Medtronic announces FDA approval of Medtronic Micra AV »

Medtronic announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 18

    Feb

CCL

Carnival

$51.01

-0.89 (-1.71%)

, NCLH

Norwegian Cruise Line

$58.83

-0.83 (-1.39%)

12:02
01/21/20
01/21
12:02
01/21/20
12:02
Recommendations
Carnival, Norwegian Cruise Line, Royal Caribbean analyst commentary  »

Coronavirus outbreak…

CCL

Carnival

$51.01

-0.89 (-1.71%)

NCLH

Norwegian Cruise Line

$58.83

-0.83 (-1.39%)

RCL

Royal Caribbean

$129.95

-5.09 (-3.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

OMI

Owens & Minor

$6.40

0.88 (15.94%)

12:00
01/21/20
01/21
12:00
01/21/20
12:00
Hot Stocks
Owens & Minor rises 16.2% »

Owens & Minor is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$6.14

0.935 (17.96%)

12:00
01/21/20
01/21
12:00
01/21/20
12:00
Hot Stocks
Mallinckrodt rises 18.2% »

Mallinckrodt is up 18.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

CSS

CSS Industries

$9.35

4.65 (98.94%)

12:00
01/21/20
01/21
12:00
01/21/20
12:00
Hot Stocks
CSS Industries rises 99.4% »

CSS Industries is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$21.49

1.58 (7.94%)

, RDY

Dr. Reddy's

$42.64

0.2 (0.47%)

11:59
01/21/20
01/21
11:59
01/21/20
11:59
On The Fly
Amarin seen in 'good position' as Vascepa patent trial proceeds »

Following the fourth day…

AMRN

Amarin

$21.49

1.58 (7.94%)

RDY

Dr. Reddy's

$42.64

0.2 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

11:57
01/21/20
01/21
11:57
01/21/20
11:57
Conference/Events
Morgan Stanley energy analysts to hold an analyst/industry conference call »

Analysts, along with Stu…

TPR

Tapestry

$28.46

-0.43 (-1.49%)

11:55
01/21/20
01/21
11:55
01/21/20
11:55
Options
Tapestry put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
01/21/20
01/21
11:55
01/21/20
11:55
General news
Treasury's $78 B in 3- and 6-month bill auctions were well received »

Treasury's $78 B in…

NIO

NIO Inc.

$5.10

0.425 (9.10%)

11:45
01/21/20
01/21
11:45
01/21/20
11:45
Options
NIO call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:42
01/21/20
01/21
11:42
01/21/20
11:42
Conference/Events
JPMorgan agribusiness analysts to hold an analyst/industry conference call »

Food &…

JAZZ

Jazz Pharmaceuticals

$151.11

0.11 (0.07%)

11:39
01/21/20
01/21
11:39
01/21/20
11:39
Conference/Events
Cantor Fitzgerald biopharma analyst to hold analyst/industry conference call »

Biopharma & Specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

AIG

AIG

$51.93

-0.95 (-1.80%)

, AON

Aon plc

$211.62

-0.15 (-0.07%)

11:36
01/21/20
01/21
11:36
01/21/20
11:36
Conference/Events
William Blair insurance analyst to hold a luncheon meeting »

Insurance Analyst Klauber…

AIG

AIG

$51.93

-0.95 (-1.80%)

AON

Aon plc

$211.62

-0.15 (-0.07%)

BRO

Brown & Brown

$41.32

-0.095 (-0.23%)

MMC

Marsh & McLennan

$114.27

0.16 (0.14%)

WLTW

Willis Towers Watson

$205.62

0.67 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 28

    Jan

  • 28

    Jan

  • 30

    Jan

  • 31

    Jan

  • 06

    Feb

  • 10

    Feb

  • 11

    Feb

  • 11

    Feb

  • 26

    Feb

TRIP

TripAdvisor

$30.53

-0.38 (-1.23%)

11:35
01/21/20
01/21
11:35
01/21/20
11:35
Options
TripAdvisor put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

11:34
01/21/20
01/21
11:34
01/21/20
11:34
Conference/Events
Stephens life science analyst to hold a group luncheon »

Life Science Tools &…

YARIY

Yara

$0.00

(0.00%)

11:33
01/21/20
01/21
11:33
01/21/20
11:33
Hot Stocks
Yara announces investigation by Spanish competition regulator »

Yara announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

$13.37

-0.275 (-2.02%)

11:29
01/21/20
01/21
11:29
01/21/20
11:29
Periodicals
Charges filed against Vale, TUV SUD for deadly dam collapse, WSJ reports »

Individuals at Vale and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$36.94

1.82 (5.18%)

11:28
01/21/20
01/21
11:28
01/21/20
11:28
Recommendations
Uber analyst commentary  »

Uber financial discipline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

LVS

Las Vegas Sands

$70.95

-3.12 (-4.21%)

11:25
01/21/20
01/21
11:25
01/21/20
11:25
Options
Las Vegas Sands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.